LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments-Reference-Cited by-同舟云学术

LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments

Published:2021-12 Issue: Volume:345 Page:119-124
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Rizos Christos V.,Skoumas Ioannis,Rallidis Loukianos,Skalidis Emmanouil,Tziomalos Konstantinos,Garoufi Anastasia,Anagnostis Panagiotis,Sfikas George,Kotsis Vasileios,Doumas Michalis,Kolovou Genovefa,Lambadiari Vaia,Dima Ioanna,Kiouri Estela,Zacharis Evangelos,Agapakis Dimitrios,Attilakos Achilleas,Antza Christina,Vlachopoulos Charalambos,Liberopoulos Evangelos N.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Familial hypercholesterolemia: the most frequent cholesterol metabolism disorder caused disease;Benito-Vicente;Int J Mol Sci,2018

2. Genetics of familial hypercholesterolemia: new insights;Vrablik;Front. Genet.,2020

3. Epidemiology of familial hypercholesterolaemia: community and clinical;Vallejo-Vaz;Atherosclerosis,2018

4. The knowns and unknowns of contemporary statin therapy for familial hypercholesterolemia;Pang;Curr. Atheroscler. Rep.,2020

5. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society;Nordestgaard;Eur. Heart J.,2013

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Profiling of differentially expressed MicroRNAs in familial hypercholesterolemia via direct hybridization;Non-coding RNA Research;2024-09

2. Real-world data on treatment patterns in at least high cardiovascular risk patients on dual and triple lipid lowering therapy in a Hellenic nationwide e-prescription database;International Journal of Cardiology Cardiovascular Risk and Prevention;2024-06

3. Obesity and atherosclerotic cardiovascular disease in adults with heterozygous familial hypercholesterolemia: An analysis from HELLAS-FH registry;Journal of Clinical Lipidology;2024-05

4. Physical signs and atherosclerotic cardiovascular disease in familial hypercholesterolemia: the HELLAS-FH Registry;Journal of Cardiovascular Medicine;2024-03-20

5. Novel Therapeutic Approaches for the Management of Elevated Lipoprotein(a): From Traditional Agents to Future Treatment Options;Life;2024-03-12